- Because many receptors and factors lead to the onset and early progression of Alzheimer's disease, targeting any one of them only slightly slows down the progression of Alzheimer's in subgroups.
- Targeting intervening points between receptor overactivation and peroxynitrite formation, slightly slows down the progression of Alzheimer's disease in most patients.
- Drugs and natural products that limit the formation of peroxynitrite, scavenge it, and reverse part of its damage largely stabilize Alzheimer's in anyone with the disease.
- Anavex 2-73, Trappsol Cyclo, and GV-971 are antioxidant drug candidates that can potentially accomplish the above.
For further details see:
Anavex 2-73, GV-971, Cyclo Therapeutics, East Asian Herbs: Antioxidants In The Treatment Of Alzheimer's Disease